Search results
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 15 hours agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This ...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 1 day agoDue to the virus’s remarkable capacity for mutation and immune evasion, the World Health...
Sarasota hospital board bucks Ladapo's claims against COVID-19 vaccines
WUSF 89.7· 2 days agoSarasota Memorial Health Care System will not endorse Florida Surgeon General Joseph Ladapo's guidance against COVID-19 vaccines ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The Motley Fool via AOL· 5 days agoNovavax is still developing a COVID-19/flu combination vaccine. It plans to start a phase 3 trial in the second half of the year, with ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Moderna. The Motley Fool has a disclosure policy. Better Buy: Inovio...
Century-old vaccine found to protect type 1 diabetics from infectious diseases
Medical Xpress· 2 days agoTwo back-to-back randomized double-blinded placebo-controlled trials found that the BCG vaccine provided continuous protection for nearly the entire COVID
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 7 days agoS. Fulcrum and Sanofi will equally share future...States. Setback For MRNA: Moderna, Inc. announced...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 4 days agoThough these two companies have massive infrastructures...companies expand their foothold in the...
